In China you can get Ozempic and Wegovy within the hour for just $100 a month

• FDA declares end to Wegovy and Ozempic shortage

  The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
  
  CBS News - 3d
• 

  Ozempic: $1,400/Month—Compounded Version: $250/Month

  The real cost? Your medical license.
  
  Inc. - 4d

• FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.

  “We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.
  
  MarketWatch - 3d
• 

  Ozempic and Wegovy officially moved off FDA's drug shortage list

  Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration's (FDA) drug shortage list nearly ...
  
  The Hill - 2d

• Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

  The FDA's decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.
  
  CNBC - 2d
• 

  A Psychologist Explains How to Shut Your Brain Up So You Can Finally Get to Sleep

  Too much going on at work to fall asleep? Research shows a simple technique called ‘cognitive shuffling’ can help quiet your brain.
  
  Inc. - 3d

• FDA says Ozempic, Wegovy are not in short supply anymore, which could impact prices

  The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply. CBS News New York reporter Ali Bauman reports on ...
  
  CBS News - 1d

• Can you dispute your tax bill with the IRS?

  Receiving an unexpected tax bill from the IRS doesn't mean you're automatically obligated to pay it.
  
  CBS News - 3h
• 

  Can Canadians get the world drinking tree sap?

  The largest producer of maple syrup now wants you to drink the sap, which it calls maple water.
  
  BBC News - 20h

More from MarketWatch

• Domino’s earnings missed on everything. Here’s why the quarter was still a win.

  Domino’s saw carryout pizza sales increase but delivery sales fall, a sign its low-income customers are still hurting the most.
  
  MarketWatch - 13m

• It’s now a stock picker’s market as more shares outperform the S&P 500. Here’s what that means for your portfolio.

  The number of individual stocks outperforming the S&P 500 has exploded since the start of 2025 after a two-year stretch of unusually concentrated performance. That translates to a broader ...
  
  MarketWatch - 51m

• Stagflation is a new threat to the stock-market rally. What investors should know.

  Worries about an unwelcome mix of inflation and stagnating economic growth are back, only this time such fears are becoming harder for investors to shake off.
  
  MarketWatch - 1h

• My mother, 63, inherited $100,000. Is she too old to invest in the stock market? What should she do with it?

  “Are the only options to create a CD ladder or leave it in a high-interest savings account?”
  
  MarketWatch - 1h

• ‘I’m a reluctant snowbird’: We’re in our 60s and own a $1 million home. Can we afford a $290K vacation home near our grandchildren?

  “We have no debt and an investment portfolio of $3.3 million.”
  
  MarketWatch - 1h

More in Business

• 

  Delta Flight Makes Emergency Landing After ‘Possible Smoke’ in Plane, F.A.A. Says

  Flight 876 returned to Hartsfield-Jackson Atlanta International Airport on Monday after the crew reported seeing haze in the flight deck.
  
  The New York Times - 8m

• Domino’s earnings missed on everything. Here’s why the quarter was still a win.

  Domino’s saw carryout pizza sales increase but delivery sales fall, a sign its low-income customers are still hurting the most.
  
  MarketWatch - 13m

• Watch: Trump and French President Emmanuel Macron hold press conference

  Trump and Macron convened in the Oval Office earlier to participate in a conference call with other leaders of the Group of Seven nations.
  
  CNBC - 15m

• Market comeback loses steam, but here's why Bristol Myers is still having a strong day

  Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
  
  CNBC - 24m

• Jamie Dimon calls U.S. government 'inefficient' and says Elon Musk's DOGE effort 'needs to be done'

  In the wide-ranging interview, Dimon addressed his push to have most workers in office five days a week and his views on Ukraine, tariffs and the U.S. consumer.
  
  CNBC - 27m